ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AZN AstraZeneca PLC

76.55
0.75 (0.99%)
04 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
AstraZeneca PLC NASDAQ:AZN NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.75 0.99% 76.55 55.00 77.24 76.49 75.43 76.47 9,026,349 05:00:07

AstraZeneca Ordered to Deliver Vaccine Doses to EU Amid Lawsuit -- Update

18/06/2021 3:10pm

Dow Jones News


AstraZeneca (NASDAQ:AZN)
Historical Stock Chart


From May 2021 to May 2024

Click Here for more AstraZeneca Charts.
   By Cecilia Butini and Ian Walker 
 

The European Commission said Friday that the Court of First Instance in Brussels has ordered AstraZeneca PLC to urgently deliver Covid-19 vaccine doses to member states, deciding on interim measures for the company amid a lawsuit brought against it by the commission and the 27 EU member states.

The court has ordered AstraZeneca to deliver 50 million vaccine doses by Sept. 27, adding to 30.2 million that the company said it has delivered in the first quarter of the year.

In the event of non-compliance with the deadline, the company will have to pay a penalty of 10 euros ($11.91) per non-delivered vaccine dose, the Commission said, reporting the court's decision.

The European Commission had originally requested 120 million vaccine doses cumulatively by the end of June, and a total of 300 million doses by the end of September. It decided on April 26 to bring legal proceedings against the company on behalf of EU member states as it sought to ensure vaccine deliveries to the bloc.

AstraZeneca said that it welcomed the court's decision on Friday, adding that it has supplied more than 70 million doses of the vaccine to the EU and expects to "substantially exceed" the required amount by the end of June.

The Commission said that the judge's decision on the interim measures--which means that the case is still open--is based on the fact that the company committed a serious breach of its contractual obligations with the EU.

AstraZeneca's general counsel Jeffrey Pott said the company has fully complied with its agreement with the European Commission.

 

Write to Cecilia Butini at cecilia.butini@wsj.com and Ian Walker at ian.walker@wsj.com

 

(END) Dow Jones Newswires

June 18, 2021 10:01 ET (14:01 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year AstraZeneca Chart

1 Year AstraZeneca Chart

1 Month AstraZeneca Chart

1 Month AstraZeneca Chart

Your Recent History

Delayed Upgrade Clock